Who should you follow on Twitter amongst all the biologists out there? Actually, it very much depends on your interests and what you want to get out of it. Below is my list of top biologists/biology writers that I, with all my many biases (see below) recommend to you to follow on Twitter, in no particular order (actually […]
A List of Top Biologists to Follow on Twitter Read More »
Nikkei is reporting that the RIKEN internal attempt to replicate so-called STAP (acid bath) cells has failed. Update: apparently, although RIKEN calls the efforts preliminary, the team tried to make STAP an amazing 22 times and 22 times it failed. The rumors for weeks in the stem cell gapevine that RIKEN itself could not get
RIKEN fails to reproduce STAP, big CDB shake up expected Read More »
What kind of scientist are you? I suspect that all of us scientists like to think that most of the work that we do is transformative and that we are a transformative scientist. In science we hear quite a lot about the importance of transformative, innovative science. But can everyone be doing transformative science all the
Is transactional science kicking transformative science’s butt? Read More »
Today has been a dark day of mourning for science following the death by suicide of Dr. Yoshiki Sasai. I did not know Dr. Sasai personally, but was very impressed with his work. His suicide leaves me feeling very sad and it seems like an appropriate time for reflection. (update I did a post on suicides by
Reflecting on Sasai tragedy, STAP, & flawed field of science Read More »
Many of this The Niche‘s readers ask about what my own lab’s research. What is the focus of the research of the Knoepfler Lab? You can go check out our lab website, but I thought it might be time to blog about what we are all about as a lab and what we have been
Knoepfler Lab: Our mission and research Read More »
I have been corresponding now and then with Dr. Teru Wakayama about the ongoing STAP situation. He asked me to pass along the following message from him for clarification on the STAP Nature paper retraction and the origin of the STAP stem cells (STAP-SC). I would like to take this opportunity to explain the reason for
New Message from Wakayama on STAP retraction & origin of STAP-SC Read More »
I asked Nature a half dozen questions about their editorial process. While they declined to answer any direct questions about the STAP cell paper situation, I thank them for answering these questions via a Nature spokesperson. The end result is an intriguing glimpse inside the editorial/review process at Nature. 1. Does Nature have any kind
Interview with Nature on their editorial process in wake of STAP Read More »
PostDoc Job Opening UC Davis School of Medicine An NIH and CIRM-funded postdoctoral fellow position in the Knoepfler Lab at UC Davis School of Medicine is open. The focus of research will be on the epigenomic and chromatin regulatory factors in human iPS cells and ES cells as well as cancer cells. Applicants must have a PhD,
Postdoc Job Opening at UC Davis School of Medicine Read More »
I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic
Interview with Bob Lanza on new ACT MSCs for MS paper Read More »
Working together with ISSCR, last week I held a short essay contest for a free registration to ISSCR 2014 in Vancouver. I received some great entries so it was a challenge to pick just one, but the winning piece was written by student Mohamed Gatie. Congratulations to Mohamed. I hope to meet him in the Vancouver
Winning Essay for ISSCR 2014 Registration Read More »